HomeNEU • ASX
add
Neuren Pharmaceuticals Ltd
Previous close
$20.69
Day range
$19.20 - $20.60
Year range
$8.61 - $22.99
Market cap
2.56B AUD
Avg Volume
369.02K
P/E ratio
17.72
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 14.14M | 7.73% |
Operating expense | 1.24M | 4.59% |
Net income | 7.52M | 87.51% |
Net profit margin | 53.16 | 74.07% |
Earnings per share | — | — |
EBITDA | 5.45M | 81.95% |
Effective tax rate | 23.78% | — |
Balance Sheet
Total assets
Total liabilities
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 299.54M | 40.51% |
Total assets | 331.25M | 45.19% |
Total liabilities | 7.98M | -11.35% |
Total equity | 323.27M | — |
Shares outstanding | 124.49M | — |
Price to book | 7.96 | — |
Return on assets | 4.11% | — |
Return on capital | 4.21% | — |
Cash Flow
Net change in cash
| (AUD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 7.52M | 87.51% |
Cash from operations | 64.15M | 724.79% |
Cash from investing | -42.79M | -10,287.26% |
Cash from financing | -19.10M | -2,414.23% |
Net change in cash | 1.38M | 118.96% |
Free cash flow | 3.66M | 62.39% |
About
CEO
Founded
2001
Website
Employees
8
